A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies.

Source:http://linkedlifedata.com/resource/pubmed/id/19228743

Clin. Cancer Res. 2009 Feb 15 15 4 1428-34

Download in:

View as

Triples

General Info

PMID
19228743